Long-lasting CRs after ibrutinib monotherapy for relapse or refractory primary CNS lymphoma (PCNSL) and primary vitreoretinal lymphoma (PVRL): Long-term results of the iLOC study by the Lymphoma Study Association (LYSA) and the French Oculo-Cerebral Lymphoma (LOC) Network (clinical trial number: NCT02542514).
作者信息
Soussain Carole, Malaise Denis, Choquet Sylvain, Ghesquières Hervé, Houillier Caroline
机构信息
Hematology, Institut Curie, Site Saint-Cloud, Saint-Cloud, France.
Ophthalmology, Institut Curie, Site Paris, Université Paris V Descartes et PSL (Paris Science et Lettre), Paris, France.
出版信息
Eur J Cancer. 2023 Aug;189:112909. doi: 10.1016/j.ejca.2023.04.025. Epub 2023 Jun 8.
PMID:37301714
Abstract
摘要
Zotero 插件